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Correlation Between Compositional and Mechanical
Properties of Human Mesenchymal Stem Cell-Collagen
Microspheres During Chondrogenic Differentiation
Chun-hei Li, M.Phil.,1,2 Tsz-Kit Chik, B.Eng.,1,2 Alfonso H.W. Ngan, Ph.D.,2 Stanley C.H. Chan, Ph.D.,3
Daisy K.Y. Shum, Ph.D.,3 and Barbara P. Chan, Ph.D.1,2
Mesenchymal stem cell (MSC)-based engineering is promising for cartilage repair. However, the compositional
mechanical relationship of the engineered structures has not been extensively studied, given the importance of
such relationship in native cartilage tissues. In this study, a novel human MSC-collagen microsphere system was
used to study the compositional mechanical relationship during in vitro chondrogenic differentiation using
histological and biochemical methods and a microplate compression assay. The mechanical property was found
positively correlating with newly deposited cartilage-relevant matrices, glycosaminoglycan, and type II collagen,
and with the collagen crosslinker density, in agreement with the presence of thick collagen bundles upon
structural characterization. On the other hand, the mechanical property negatively correlates with type I collagen
and total collagen, suggesting that the initial collagen matrix scaffold of the microsphere system was being
remodeled by the differentiating human MSCs. This study also demonstrated the application of a simple,
sensitive, and nondestructive tool for monitoring the progression of chondrogenic differentiation of MSCs in
tissue-engineered constructs and therefore contributes to future development of novel cartilage repair strategies.
Introduction
Cartilage injuries are very common. Owing to theacellular and avascular nature, cartilage itself has very
limited ability to repair and regenerate.1–5 Current treat-
ments have obvious deficiencies. Arthroscopic techniques
alleviate pain instead of regenerating the cartilage,4–8 and
microfracture techniques lead to the formation of more
vulnerable fibrocartilage.4–7,9,10 Autologous chondrocyte im-
plantation5,7,11 and autogenic or allogenic tissue transplan-
tation4,5,7,11–13 have donor availability problem and donor-site
morbidities. Therefore, better treatment options such as
autologous stem cell-based therapies are needed.
Bone marrow mesenchymal stem cells (MSCs) are attrac-
tive cell source for tissue engineering. This is because of their
relatively safe and easy accessibility from the donor, the
ability of self-renewal and differentiating into multiple line-
ages of cells,14,15 genetic stability, immunologically privileged
status,14,16 and better social and ethics acceptability than
embryonic stem cells. In MSC-based cartilage tissue engi-
neering, these cells are expected to differentiate into chon-
drogenic lineages and then remodel the biodegradable
scaffolds into a tissue structure simulating the native cartilage.
The compositional and mechanical relationship of native
cartilage tissues has long been studied.17–19 The mechanical
function performed by cartilage mainly associates with its re-
sistance to compression. Compressive modulus, shear modulus,
and Poisson’s ratio of native cartilage have been found to as-
sociate with the amount of extracellular matrix (ECM), in-
cluding collagen,1,2,17,18,20–22 collagen crosslinks,17,23–26 and
proteoglycans,1,5,27,28 of the tissue. Such relationship is equally
important in stem cell-based engineered tissues for better un-
derstanding of the mechanisms of matrix remodeling in differ-
ent scaffold systems. Nevertheless, despite a large amount of
studies using MSCs in different scaffolds for cartilage repair,29–31
the compositional mechanical relationship via matrix remodel-
ing of engineered constructs are not extensively studied.
Previously, we have established a novel collagen microen-
capsulation technique32 to entrap cells such as MSCs,33,34
embryonic stem cells,35 chondrocytes,36 and HEK 293 cells37,38
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in microspheres made of dense fibrous type I collagen
meshwork, which provides a suitable 3D matrix environment
for cells to survive, proliferate, and migrate.33 Human MSCs
(hMSCs) that resided in these microspheres were also proven
to retain stem cell characteristics, including their im-
munophenotype, multipotent differentiating potential, and
self-renewal capacity.33 Moreover, this microsphere system
provides a template collagen fiber meshwork for both mature
cells such as chondrocytes36 and differentiating stem cell such
as embryonic stem cells35 and MSCs34,39 to remodel upon
chemical induction.
In this study, we hypothesize that the temporal changes of
various compositional parameters would closely associate
with the change in the mechanical parameter, namely, the
elastic modulus of the microsphere during chondrogenic dif-
ferentiation of the entrapped hMSCs. Specifically, we aim to
characterize the in vitro chondrogenic differentiation of
hMSCs in collagen microspheres and establish the association
among different compositional parameter with the mechanical
parameter. Specifically, reduced elastic modulus (Er) of the
microspheres will be measured using a microplate compres-
sion technique established in our lab.40 Cartilage-relevant
ECM components, including collagen type II and glycosami-
noglycans (GAGs), and pyridinoline (PYD) crosslink density
will be assessed using both histological and biochemical
methods. Correlation coefficients between various biochemi-
cal composition parameters and the mechanical parameter
will be obtained. The significance of the established associa-
tion between biochemical composition and mechanical prop-
erty of the microsphere would help us to better understand
how hMSC remodel the scaffold to form a cartilage-like
structure during chondrogenic differentiation and therefore
may contribute to future novel cartilage repair strategy.
Materials and Methods
Overall research design
hMSCs were microencapsulated in collagen microspheres
and induced to differentiate toward chondrogenic lineages
using a chemically defined culture medium. At different time
points postdifferentiation, the microsphere populations were
divided, pooled, and processed for histological, biochemical,
structural, and mechanical characterization. Apart from rou-
tine histological staining, histochemical staining for GAGs and
immunohistochemical staining for type I and II collagen were
conducted. Quantitative measurements of the biochemical
compositions of the microspheres, namely, hydroxyproline
(HYP) for total collagen content, uronic acids for GAG content,
type I and II collagen, and PYD collagen crosslinker, have been
conducted using either chemical or immunochemical methods.
Scanning electron microscopy (SEM) was also conducted to
reveal the fibrous structures of the microspheres during chon-
drogenic differentiation. A microplate step-change compres-
sion assay has been used to measure theEr of the microspheres.
Finally, correlation coefficients between the biochemical com-
positional parameters and the mechanical parameter of the
differentiating microspheres have been calculated.
Culture of hMSCs
hMSCs from bone marrow from three donors (male, age
47–49) were kindly provided by Dr. G.C.F. Chan from the
Department of Paediatrics and Adolescent Medicine of the
same institution. hMSCs were isolated and cultured as pre-
viously described.41 All procedures were approved by the
Combined Clinical Ethics Committee of the University of
Hong Kong and Hong Kong West Cluster Hospitals of Hos-
pital Authority. In brief, the cells were cultured in the growth
medium containing Dulbecco’s modified Eagle’s medium–
low glucose (Gibco), 10% fetal bovine serum (Gibco), 100 U/
mL penicillin (Gibco), 100mg/mL streptomycin (Gibco), and
2 mM L-glutamine (Gibco), incubated at 378C in a humidified
atmosphere with 5% CO2. The culture medium was replaced
every 3–4 days. The cells were subcultured up to passage 6 for
fabrication of microspheres. Immunophenotype, self-renewal
capacity, and multidifferentiating potential of the hMSCs
were characterized in a previous study.33
Fabrication of collagen–hMSC microspheres
Collagen–hMSC microspheres were fabricated as previ-
ously described33 and fabrication parameters optimized as
reported elsewhere.34 In brief, cell suspension was mixed
with neutralized rat tail type I collagen solution (BD Bios-
ciences) in an ice bath. The cell–collagen mixture was diluted
by the culture medium to a final cell density of 1106 cells/
mL and a final collagen concentration of 1 mg/mL. Droplets
of the mixture in volumes of 50mL and 100 mL were pipetted
onto UV-irradiated parafilm placed in separate Petri dishes.
The 100 mL droplets were used to produce microspheres of
larger sizes to ease the sample preparation process for SEM
analysis. Gelation of the collagen–hMSC droplets was
brought about by incubation at 378C in a humidified atmo-
sphere consisting of 5% CO2 for 45 min. The gelated droplets
were then cultured in the same medium for 5 days to allow
for cell-induced contraction. Microspheres made from 50mL
droplets were used for subsequent biomechanical, biochem-
ical, and histological studies, whereas those made from
100 mL droplets were used for ultrastructural study.
Chondrogenic differentiation of hMSCs
in collagen microspheres
Chondrogenic differentiation of hMSCs encapsulated in the
collagen microspheres was brought about by culturing the
collagen–hMSC microspheres in the chondrogenic differen-
tiation induction medium, defined as Dulbecco’s modified
Eagle’s medium–high glucose, with the supplementation of
10 ng/mL recombinant human TGF-b3 (Preprotech), 100 nM
dexamethasone (Sigma-Aldrich), 0.1 nM L-ascorbic acid
2-phosphate (Fluka), 6 mg/mL insulin (Merck), 6mg/mL
transferring (Sigma), 1 mM sodium pyruvate (Gibco), 0.35 mM
L-proline (Merck), and 1.25 mg/mL bovine serum albumin
(Sigma). The medium was changed every 2 days and lasted
for 3 weeks. Microspheres were harvested on days 0, 7, 14,
and 21 upon the addition of chondrogenic differentiation in-
duction medium for subsequent analyses. Cell-free collagen
microspheres can also be used as the control, but these mi-
crospheres disintegrated and therefore weakened over time
such that subsequent analyses could not be performed.
Histological, histochemical, and immunohistochemical
staining of ECM components
Harvested microspheres were fixed in 4% phosphate-
buffered saline (PBS)–buffered paraformaldehyde (BDH),
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paraffin embedded, and sectioned at 5 mm thickness. Routine
hematoxylin and eosin staining was performed to reveal
cell morphology. Alcian blue histochemical staining was
performed to observe the presence of GAGs. Immuno-
histochemical analysis was performed for type I and type
II collagen, using primary mouse monoclonal antibodies
against type I collagen (Sigma) and type II collagen (EMD),
respectively. These antibodies exhibited cross-reactivity with
human samples. After overnight incubation with the pri-
mary antibodies at 48C, sections were incubated with anti-
mouse secondary antibodies (Dako). The incubation lasted
for 30 min at room temperature, followed by another 30 min
with avidin–biotin–peroxidase complex (Vector Labora-
tories). Immunostaining was detected colorimetrically using
diaminobenzidine (Dako). Sections were counterstained with
hematoxylin.
Quantitative measurement of ECM components
Uronic acid analysis was adopted instead of the widely
used 1,9-dimethylmethylene blue (DMMB) assay. Uronic
acid is a regular component of disaccharide repeating units
of chondoroitin sulfates and hyaluronans, major GAGs
found in the ECM of articular cartilage.42 This assay offers an
advantage over the DMMB assay because it is independent
of the GAG size and the degree of sulfation.43 In brief, each
microsphere was digested overnight at 608C with 300 mg/mL
papain (Sigma) in 50 mM phosphate buffer (Sigma; pH 6.5)
containing 5 mM L-cysteine (Calbiochem) and 5 mM ethyle-
nediaminetetraacetic acid (Sigma), followed by sequential
precipitation at 48C in 0.5% cetylpyridinium chloride (Sigma)
in 0.025 M acetate buffer (pH 5.8; Sigma), and then sodium
acetate-saturated ethanol. The dried GAG product was dis-
solved in a defined volume distilled water for the assay.44
Procedures for uronic acid analysis were described else-
where.43 Briefly, 200 mL of 0.025 M di-sodium tetraborate 10-
hydrate (Merck) in concentrated sulfuric acid was added to
each precooled test GAG solution and then heated at 1008C
for 10 min. Twenty microliters of 0.125% carbazole (Eastman
Kodak) in absolute ethanol was then added to each of the
cooled mixtures and heated at 1008C for another 15 min to
produce the colored product. After cooling to room tem-
perature, the optical density of the product was read at
530 nm with a microplate reader. Optical densities of stan-
dard glucuronic acid (Sigma) with different concentrations
were plotted in a standard curve. Hexuronic acid content of
the test sample was determined from the standard curve
after correction for dilution effects.
HYP assay was used to determine the content of HYP,
which is the marker for total collagen, presented in the mi-
crospheres as described previously.45,46 In brief, 10 micro-
spheres at each time point were pooled together and
hydrolyzed in 200mL of 6 N hydrochloric acid (Sigma) at
1108C for 18 h in a hydrolysis tube (Pierre) after being flushed
with nitrogen gas for 30 s. The acid hydrolyzate was neu-
tralized by 6 N sodium hydroxide (NaOH). One hundred
microliters of neutralized acid hydrolysate (pH 6–7) was ad-
ded to a 96-well plate and oxidized by 50mL 0.05 M chlora-
mine T (Sigma) for 20 min, followed by incubating with 50mL
3.15 M perchloric acid (Sigma) for 5 min. Oxidized samples
were then mixed with 50mL p-dimethylaminobenzaldehyde
(20%, w/v; Sigma) and incubated at 608C for 20 min to
produce coloured products. The optical densities of the as-
sayed samples were measured at 557 nm with a microplate
reader. HYP content was computed by linear interpolation
using trans-4-hydroxy-L-Proline (Sigma) as standard.
Collagen type II enzyme-linked immunosorbent assay
(ELISA; MD Bioscience) was used to determine the amount
of type II collagen presented in the microspheres. Twenty
microspheres at each time point were pooled together and
digested by pepsin in 0.5 N acetic acid (Sigma; collagen:
pepsin¼ 10:1, w/w) to extract type II collagen. Pretreatment
with 0.2 M NaOH was performed for samples harvested on
days 14 and 21 at 48C for 24 h to remove any proteoglycans
as it has been demonstrated to improve the collagen ex-
traction efficiency. Pepsin was digested at 208C for 18 h with
constant stirring. Insoluble residues were separated by cen-
trifugation at 15,000 rpm for 15 min and supernatants were
collected.47 They were adjusted to pH 8.0 with 1 M NaOH,
followed by the digestion using 1/10 starting volume of pan-
creatic elastase solution (1 mg/mL in 1TBS, pH 7.8–8.0;
Sigma) at 48C overnight. Extracted type II collagen was mea-
sured according to the manufacturer’s instructions. In brief,
samples and standards were added to the supplied 96-well
plate and incubated with the capture antibodies for 2 h. The
wells were then washed and loaded with biotinylated anti-
bodies for another 2 h, followed by a wash and incubation with
streptavidin-horseradish peroxidase (HRP) for 30 min. After all,
the plate was washed again and incubated with tetramethyl-
benzidine (TMB) solution for 20 min. Sulfuric acid was added as
the final step to stop the reaction and obtain color products.
Absorbance was read at 450 nm. All the incubation steps were
carried out at room temperature. Type II collagen was quanti-
fied by linear interpolation with the standard.
Rat collagen type I ELISA (Chondrex) was used to deter-
mine the amount of type I collagen presented in the micro-
spheres. Five microspheres at each time point were pooled
together for collagen extraction using the same protocol as
stated above. Extracted type I collagen was accessed ac-
cording to the manufacturer’s instructions. In brief, samples
and standards were added to the supplied 96-well plate
precoated with capture antibodies and were incubated for
2 h. The wells were then washed and loaded with detection
antibodies for another 2 h, followed by a wash and incubation
with streptavidin peroxidase for 1 h. Afterward, the plate was
washed again and incubated with orthophenylene-diamine
(OPD) solution for 30 min. Sulfuric acid was added as the
final step to stop the reaction and obtain colored products.
Absorbance was read at 490 nm. All the incubation steps
were carried out at room temperature. Rat type I collagen
was quantified by linear interpolation with the standard.
MetraPYD ELISA kit (Quidel Corporation) was used to
quantify the amount of PYD, which is one of the major col-
lagen crosslinkers,23,48 presented in the microspheres. The
acid hydrolyates obtained previously in HYP assay was used
for PYD quantification, following the procedures instructed
by the manufacturer. In brief, samples or standards were
added to each well of the coated strips, followed by the
addition of anti-pyridinium crosslinks antibodies conjugated
to alkaline phosphate. The mixtures were incubated at 48C
for 3 h in dark. Afterward, each well was washed and sub-
strate solution containing ethanolamine and magnesium
chloride was added. Incubation at room temperature for
another 1 h was carried out and the substrate reaction was
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stopped afterward by NaOH. Color products were produced
and the absorbance was read at 405 nm. The PYD amount
was determined from the standard curve obtained.
Measurement of elastic modulus of the microspheres
A microplate rate-jump compression method40 was used
to determine the Er of the collagen–hMSC microspheres at
different time points during chondrogenic differentiation. Er
is chosen because it reflects the elastic components and
therefore the resilience of the structures, which is character-
istic to cartilage tissue. In brief, custom-made rigid and
flexible microplates were mounted onto the metal holders of
two separately controlled micromanipulators (MP-285 mo-
torized micromanipulator; Sutter Instrument). A micro-
sphere was attached onto the rigid microplate for around
5 min to assure firm adhesion, followed by the compression
in 1PBS by the flexible microplate, which had been cali-
brated for stiffness (k) using an electronic balance and a
height gauge.40 A step change compression protocol was
employed to impose a sudden change in displacement rate
during the process so as to eliminate the viscous component
of the viscoelastic deformation of the microsphere.40,49 Sixty
percent strain (i.e., 60% of the diameter of the microsphere in
the compression axis) was set to be the displacement at the
fixed end of the flexible microplate (d). The compression
started off with an initial displacement rate ( _d ) of 1mm/s,
followed by a sudden change to 2mm/s ( _dþ ) upon reaching
half of d. The whole compression process was captured by a
digital camera (CoolSNAP ES; Photometrics) and the image
was analyzed by image analysis software Metamorph (Mo-
lecular Devices Corporation). The free end displacement (d0)
of the flexible microplate was tracked by the object tracking
module of the software and the radius (a) in the contact re-
gion between the two bodies was measured. Er was calcu-
lated using the equation Er¼ E
1 v2 ¼
k
a
 
D _d
D _d
¢  1
!
, where
D _d and D _d
¢
represent the displacement rate change for the
fixed and free end of the flexible microplate, respectively, at
the time the sudden displacement rate change was imposed.
Size measurement of microspheres
during chondrogenic differentiation
To estimate the effect of cells-induced contraction, the si-
zes of 36–40 microspheres at each time point during differ-
entiation were measured using Metamorph. As the
microsphere was not perfectly spherical, its dimensions
parallel and perpendicular to the axis of compression were
recorded. The mean of the two parameters was taken to be
the effective dimension of the microsphere.
SEM analysis of the microspheres
SEM was used to examine the ultra-structure of collagen–
hMSC microspheres. Microspheres harvested at different
time points were rinsed with 1PBS and fixed by 2.5%
glutaraldehyde (Sigma) for 2 h at room temperature. They
were then dehydrated through a graded series of ethanol
(50%, 70%, 80%, 90%, 95%, and 100% for twice) and then
critical point dried. The dried samples were fractured using a
sharp blade to expose their cross sections and were mounted
onto a metal stub using carbon cement. The samples were
sputtered with gold for 20 s for electrical conductance during
SEM examination.
Statistical analysis
Differences on microsphere dimension was analyzed by
one-way analysis of variance (ANOVA) with Bonferroni’s
post-hoc test while those on Er, GlcUA, HYP, PYD, and col-
lagen type I and II of the microspheres at different time
points of differentiation and in different subjects were ana-
lyzed using two-way ANOVA (General Linear Model, Uni-
variate) with Bonferroni’s post-hoc tests. Nonparametric
Spearman’s Rho correlation coefficients between various
biochemical compositional parameters and the mechanical
property Er of the microspheres in each subject were used to
reveal their association during differentiation. Nonpara-
metric tests were used because sample size per subject was
small. All statistical tests were performed using SPSS 17.0
(SPSS). A significance level was set at 0.05. Values were re-
ported as mean standard deviation unless otherwise
specified.
Results
Reduction in size of microspheres
Upon chondrogenic differentiation, the hMSC-encapsulated
collagen microspheres contracted over time (Fig. 1A–D).
Their sizes decreased significantly by half on day 7 (Fig. 2A),
whereas subsequent decline at 14 and 21 day postdif-
ferentiation was no longer significant. One-way ANOVA
with Bonferroni post-hoc test showed significant differences
between all time point and day 0 ( p< 0.05).
Decrease in type I collagen and total collagen
Type I collagen has great homology across different spe-
cies. The antibody used for immunohistochemistry reacts
with both human and rat type I collagen. As a result, type I
collagen detected by immunohistochemistry include both rat
type I collagen in the template and the newly synthesized
human type I collagen if any. As shown in Figure 1E–H,
immunopositive staining was found at all time points. Type I
collagen was largely homogeneous throughout the micro-
sphere before chondrogenic differentiation (Fig. 1E). Thick
bundle-like immunonegative structures were detected at day
7 and 14 postdifferentiation (Fig. 1F, F1, G), whereas nodules
with immunonegative staining could be found throughout
the microsphere in these samples. At 21 days post-
differentiation, further increase in regions with im-
munonegative staining was detected particularly at the
center (Fig. 1H). This decreasing trend was revealed by
quantitative measurement of type I collagen in all three
subjects using ELISA (Fig. 2B). Two-way ANOVA showed
that the time factor ( p¼ 0.001) but not the subject factor
( p¼ 0.107) significantly affected type I collagen. Bonferroni’s
post-hoc tests on the time factor showed that day 21 was
significantly different from day 0 and 7 ( p 0.009) and day
14 was significantly different from day 7 ( p¼ 0.009). HYP is
the marker for total collagen including type I collagen used
for fabrication of the microspheres and other types of col-
lagen newly synthesized by the differentiating hMSCs.
As shown in Figure 2C, the total collagen content de-
creases progressively during the chondrogenic differentiation
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process in all three subjects, but the change was more dra-
matic in subject 1. Two-way ANOVA showed that both the
time factor ( p< 0.001) and the subject factor ( p< 0.001) sig-
nificantly affected HYP. Bonferroni’s post-hoc tests on the time
factor showed that day 21 was significantly different from all
other time points ( p 0.038), day 14 was significantly differ-
ent from day 0 ( p< 0.001) and day 21 ( p¼ 0.038), day 7 was
significantly different from day 0 ( p¼ 0.002), and day 21
( p< 0.001) and day 0 were significantly different from all
other time points ( p 0.002). Moreover, Bonferroni’s post-hoc
test on subject factor showed that subject 1 was significantly
different from the other two subjects ( p< 0.001).
Increase in type II collagen and GAGs
Type I collagen was the only scaffold material entrapping
the hMSCs within the microsphere. Therefore, any matrix
components other than type I collagen should be newly
synthesized by the entrapped cells. ECM markers for chon-
drogenic lineages include type II collagen and proteoglycans.
Figure 1I–L shows the immunohistochemical staining of type
II collagen in microspheres during chondrogenic differenti-
ation. Negative staining was found before differentiation
(Fig. 1I). Slight immunopositive staining of type II collagen
was found at day 7 postdifferentiation (Fig. 1J) followed up
by an increase in both area and intensity of the staining at
day 14 and 21 postdifferentiation (Fig. 1K, L, L1). Quantita-
tive analysis of type II collagen using ELISA confirmed the
increasing trend particularly on day 14 and 21 post-
differentiation in all three subjects (Fig. 2D). Two-way AN-
OVA showed that both the time factor ( p< 0.001) and the
subject factor ( p< 0.001) significantly affected type II colla-
gen. Bonferroni’s post-hoc tests on the time factor showed that
both day 21 and day 14 were significantly different from
days 7 and 0 ( p 0.001). Moreover, Bonferroni’s post-hoc
tests on the subject factor showed that all three subjects are
significantly different from one another ( p 0.009). Minimal
staining for GAGs was found in microspheres before chon-
drogenic differentiation was induced (Fig. 1M). Both area
and intensity of the GAG staining were found increased after
7 days (Fig. 1N). Intensive staining for GAG was found at
day 14 and 21 postdifferentiation (Fig. 1O, P). Quantitative
analysis of GlcUA, which is the regular component of GAG
chains, confirmed the trend of continuous increasing pro-
teoglycan content over time in all three subjects (Fig. 2E).
Two-way ANOVA showed that both the time factor
( p< 0.001) and the subject factor ( p¼ 0.02) significantly
contributed to the changes in GlcUA. Bonferroni’s post-hoc
FIG. 1. Histological, histochemical, and immunohistochemical characterization of collagen–hMSC microspheres at different
time points during chondrogenic differentiation. (A–D) H&E staining. (E–H) Immunohistochemistry of type I collagen (Col I).
(I–L) Immunohistochemistry of type II collagen (Col II). (M–P) Alcian blue (AB) histochemical staining for glycosamino-
glycans. F1, magnified view of F; L1, magnified view of L. Arrows: thick collagen bundles. Scale bar: 100mm. hMSC, human
mesenchymal stem cells; H&E, hematoxylin and eosin. Color images available online at www.liebertonline.com/ten.
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tests on the time factor showed that day 21 was significantly
different from all other time points ( p 0.039), day 14 was
significantly different from day 0 ( p¼ 0.001) and day 21
( p¼ 0.039), day 7 was significantly different from day 21
( p< 0.001), and day 0 was significantly different from all
time points ( p 0.001) but day 7. Nevertheless, Bonferroni’s
post-hoc tests on the subject factor did not reveal any signif-
icant difference ( p 0.108).
Bundle formation and increased
collagen crosslinker density
SEM analysis of the collagen–hMSC microsphere before
chondrogenic differentiation showed a highly randomized
meshwork of collagen (Fig. 3A). Collagen fibers were found
randomly distributed and intercross with each other.
Nevertheless, they become more organized as chondrogenic
differentiation goes on (Fig. 3B–D). Specifically, closely
packed fibers were found, forming thick bundles throughout
the microspheres, particularly at days 14 and 21 post-
differentiation (Fig. 3C, D). Such structural changes are
highly agreeable with the bundle structures observed in
immunohistochemistry of both type I (Fig. 1F, F1) and II (Fig.
1L, L1) collagen, suggesting the enhanced organization of the
matrix by the differentiating hMSCs. Moreover, nonfibrous
ground substances coating the fibrils were observed
throughout the matrix particularly at later time points (Fig.
3C, D). Further, the density of PYD, a major nonreducible
collagen crosslinker, has been found significantly increasing
over time in all three subjects (Fig. 2F), suggesting an en-
hanced organization of collagen matrix. This correlates well
with the presence of thick bundles observed in SEM (Fig. 3C,
D). Two-way ANOVA showed that the time factor
( p¼ 0.002) but not the subject factor ( p¼ 0.121) significantly
affected PYD density. Bonferroni’s post-hoc tests on the time
factor showed that day 21 ( p¼ 0.002) and day 4 ( p¼ 0.007)
were significantly different from day 0.
Increase in Er
Figure 4A and B shows the collagen–hMSC microsphere
before and after the step change compression assay, which is
a rapid, simple, and nondestructive procedure, from which
the contact radius between the microsphere and the soft
plate was obtained for subsequent calculation. Figure 4C
shows the raw data and the linearly regressed slopes in the
FIG. 2. Physical and bio-
chemical characterization of
collagen–hMSC microspheres
at different time points dur-
ing chondrogenic differentia-
tion. (A) Diameter of
microspheres (n¼ 36–40). (B)
Type I collagen (n¼ 2 to 4,
each sample is a pool of 5
microspheres). (C) Hyp con-
tent (n¼ 2–3, each sample is a
pool of 10 microspheres). (D)
Type II collagen (n¼ 3 to 4,
each sample is a pool of 20
microspheres). (E) Uronic
acid content (n¼ 3 to 9). (F)
Pyd-to-Hyp ratio (n¼ 2 to 3,
each sample is a pool of 10
microspheres). N¼ 3 subjects
for biochemical characteriza-
tion. Hyp, hydroxyproline;
Pyd, pyridinoline.
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step-change compression protocol. From which, the differ-
ence in slopes of the two compression steps was obtained for
subsequent calculation. The mean Er with standard deviation
of the microspheres of three subjects predifferentiation at day
0 was 4.2 2.5 kPa. Upon chondrogenic induction, the mean
Er of the differentiating microspheres from three subjects was
increased to 58 38 kPa, 65 44 kPa, and 96 48 kPa on
days 7, 14, and 21 postdifferentiation, respectively, ac-
counting for 13.8-, 15.5-, and 22.9-fold of increase. Two-way
ANOVA showed that both the time factor ( p< 0.001) and the
subject factor ( p< 0.001) significantly affected Er. Bonferro-
ni’s post-hoc tests showed that day 21 was significantly dif-
ferent from all other time points ( p 0.02), day 14 was
significantly different from day 21 and 0 ( p< 0.02) but not
day 7, day 7 was significantly different from days 21 and 0
( p< 0.003) but not day 14, and day 0 was significantly dif-
ferent from all other time points ( p< 0.001). Moreover,
Bonferroni’s post-hoc tests on the subject factor showed that
subject 1 was significantly different from the other two
subjects ( p< 0.001).
Association between biochemical compositional
parameters and mechanical parameter
Table 1 shows the nonparametric correlation coefficients
with significance values between the compositional param-
eters and the Er of the microspheres during differentiation.
Specifically, HYP showed a strong negative correlation with
Er in all three subjects (0.973, 0.714, 0.905), whereas type
I collagen also showed a moderate negative correlation in all
subjects (0.582, 0.479, and 0.555). On the other hand,
type II collagen (0.510, 0.753, and 0.633) and GAGs (0.469,
0.945, and 0.877) showed positive correlation with Er with
moderate to high coefficients, whereas PYD density showed
strong positive correlation (0.733, 0.810, and 0.810). Corre-
lation coefficients for HYP, GAGs, and PYD density were
statistically significant in all three subjects ( p< 0.05). Corre-
lation coefficient for type I collagen was statistically signifi-
cant in one subject ( p¼ 0.029) but marginal for the other two
subjects ( p¼ 0.077 and 0.162). Similarly, correlation coeffi-
cient for type II collagen was statistically significant in one
subject ( p¼ 0.019) but marginal in the other two subjects
( p¼ 0.062 and 0.067).
Discussion
This study reported the histological, biochemical, struc-
tural, and mechanical characterization of collagen–hMSC
microspheres during chondrogenic differentiation and dem-
onstrated close correlation between the compositional pa-
rameters and the mechanical property of the micropheres.
Our results suggested that the differentiating hMSCs are
actively remodeling the template type I collagen meshwork
in the microspheres, depositing new ECM, including pro-
teoglycans and type II collagen, and organizing the fibrous
matrix via collagen crosslinking. This study helps us to better
understand how hMSC remodel the microsphere matrix
during chondrogenic differentiation and therefore contrib-
utes to future development of novel cartilage repair strate-
gies. Finally, this study also illustrated the application of a
simple sensitive and nondestructive method monitoring the
temporal change in elastic modulus of soft and viscoelastic
structures.
Matrix remodeling activities of the differentiating
hMSCs contribute to the change in mechanical
property of the microspheres
The first matrix compositional change is the increase in newly
deposited cartilage-relevant ECMs, including proteoglycans
FIG. 3. Scanning electron
microscopy of the collagen
fibril meshwork of collagen–
hMSC microspheres at differ-
ent time points during chon-
drogenic differentiation. (A)
Day 0. (B) Day 7. (C) Day 14.
(D) Day 21. Magnifications:
100K; *, parallel bundles; #,
ground substances coating the
collagen fibrils.
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and type II collagen. Despite the differences in types of stem
cells and scaffolds used, this characteristic association has
been reported in other tissue-engineered constructs.50–52
Awad et al. reported a progressive increase in equilibrium
shear modulus and complex shear modulus for constructs
made of agarose, alginate, and gelatin with adiposed-derived
adult stem cells, whereas GAG and HYP contents were
found to increase continuously with time50; Mauck et al. re-
ported the chondrogenesis of bovine MSCs in agarose cul-
ture and demonstrated an increase in Young’s modulus and
dynamic modulus with collagen and GAG52; the hMSCs
seeded silk scaffolds reported by Hofmann et al. also dem-
onstrated a significant increase in the aggregate modulus
together with a progressive increase in GAG and expression
FIG. 4. Mechanical characteriza-
tion of collagen–hMSC micro-
spheres at different time points
during chondrogenic differentia-
tion. (A, B) Phase-contrast images
showing a collagen–hMSC micro-
sphere before (A) and after (B) the
simple step-change compression
assay (arrow, contact point for
tracking path of the soft microplate
compression; 2a, diameter of the
instantaneous contact region be-
tween the microsphere and the soft
microplate); (C) A representative
displacement (micrometers) time
(second) curve of collagen–hMSC
microsphere during the step-change
compression assay (d0_1, raw data
collected during compression with
displacement rate 1; d0_2, raw data
collected during compression with
displacement rate 2; linear (d0_1),
best fit linear regression line for
compression with displacement rate
1; linear (d0_2), best fit linear re-
gression line for compression with
displacement rate 2. (D) Er of colla-
gen–hMSC microspheres harvested
at different time points post-
differentiation (error bars, standard
deviations; n¼ 3 to 9 per time
point). Er, reduced elastic modulus.
Color images available online at
www.liebertonline.com/ten.
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of type II collagen.51 The second matrix compositional
change is related to the structural organization of collagen
fibers as demonstrated by both the increase in the density of
the collagen crosslinker PYD and the presence of thick col-
lagen bundles in SEM analysis. PYD is generally known to
contribute to the tensile properties of tendons46,53 and liga-
ments,54,55 and has been demonstrated to associate with both
the compressive17 and tensile properties56 of articular carti-
lage. The significance of PYD in contributing to the me-
chanical properties of tissue-engineered constructs has been
demonstrated by the significantly lower equilibrium modu-
lus and secant modulus of chondrocyte-seeded alginate
beads when exposed to prolonged crosslink inhibition.57 The
positive association between PYD and mechanical properties
in engineered tissue constructs has previously been reported
in chondrocyte-seeded polylactic acid and polyglycolic
acid.58 Moreover, the positive association between HYP
normalized PYD and Er in the microspheres is very relevant
to cartilage tissue engineering as type II collagen is more
heavily crosslinked than other types.48 This may also par-
tially explain the net and significant increase in Er of the
microspheres even though the amount of type II collagen
being deposited is minute. A third compositional change is
the net decrease in type I collagen and total collagen (HYP).
This negative association between Er and type I collagen or
total collagen should be a result of the degradation activity of
the differentiating hMSCs. The scaffold material used in
fabricating the microspheres is type I collagen, which serves
as a degradable template meshwork for hMSCs to remodel
as they differentiate. Although the differentiating hMSCs
may also synthesize type I collagen, the overall decreasing
trend of type I collagen and total collagen suggests that the
degradation of the template material outweighs the newly
deposited type I collagen if any. Involvement of various
enzymes or proteases in matrix remodeling during chon-
drogenesis has been previously reported.59–63 Matrix me-
talloproteinase 13 is one of the enzymes known to degrade
collagen type I, II, III, and IV59–61 and has been shown up-
regulated during chondrogenesis.62,63 The amount of type I
collagen initially used in fabricating the microsphere is way
higher (tens of microgram level) than that deposited (nano-
gram level for type II collagen and microgram level for type I
collagen). As a result, the degradation rate of the template
material outweighs the deposition rate of any collagen sub-
type if any. A fourth factor contributing to the increase in Er
of the microspheres is the reduction in size and thus the
volume of the microsphere due to hMSC-induced matrix
contraction. This leads to a higher matrix density and results
in a more compact and solid structure in the microsphere.
Nevertheless, the size has reduced only less than half during
differentiation, whereas the increase of the Er was >24-fold,
suggesting that the compaction effect due to size reduction
could not explain the tremendous increase in Er of the
microspheres.
Advantages and limitations of the current study
The microplate compression technique established in our
lab40 presents a simple method in measuring elastic modulus
of small soft and viscoelastic structures particularly those
hydrogel-based including the commonly used alginate and
agarose (data not shown). Utilizing calibrated microplates
made of different materials and with different bending
stiffness, this method is able to measure structures with a
wide range of elastic modulus, ranging from *100 Pa for
cell-free collagen microspheres40 to hundreds of kPa for mi-
crospheres with chondrogenic differentiated hMSCs.40 The
close correlations between the compositional changes of the
microspheres and their elastic modulus established in this
work suggest that the microplate method can be used to
monitor the progression of chondrogenic differentiation
particularly with matrix remodeling activity of hMSCs.
Specifically, we can use this method to determine the end
point of in vitro manipulation of the microspheres before
implantation. Other advantages of this method include its
nondestructive nature and the small amount of samples re-
quired. The assay is a two-step compression protocol using a
very soft and flexible microplate, which will not damage the
microsphere at all. Moreover, a single microsphere made of
as little as 2.5 mL of cell–gel mixture containing hundreds of
cells is able to yield a data point, comparing with the bio-
chemical assays where pooling tens of microspheres is re-
quired to yield one detectable data point, suggesting the
excellent sensitivity of this microplate compression assay.
This work also reveals the subject variability in using human
cells and suggests that multiple subjects need to be used in
this kind of studies. Specifically, significant subject variabil-
ity was detected in HYP, type II collagen, and Er but not in
GAG, type I collagen, and PYD density. Moreover, the
compositional mechanical correlation study also revealed the
subject variability in type I and II collagen but not in HYP,
PYD, and GAGs. The subject variability could be inherent to
Table 1. Nonparametric Spearman’s Rho Correlation Coefficients Between Various Biochemical
Compositional Parameters and the Reduced Elastic Modulus (Er) of Human Mesenchymal Stem
Cell–Collagen Microspheres Fabricated from Three Subjects During Chondrogenic Differentiation
Subject no. 1 Subject no. 2 Subject no. 3
Correlation
coefficient with Er p-Value
Correlation
coefficient with Er p-Value
Correlation
coefficient with Er p-Value
Hydroxyproline (Hyp) 0.937a <0.001 0.714a 0.047 0.905a 0.002
Type I collagen 0.582a 0.029 0.479 0.162 0.555 0.077
Uronic acid (GlcUA) 0.469a 0.005 0.945a <0.001 0.877a <0.001
Pyridinoline to hydroxyproline
ratio (Pyd/Hyp)
0.733a 0.016 0.810a 0.015 0.810a 0.015
Type II collagen 0.51 0.062 0.753a 0.019 0.633 0.067
aData with statistical significance, that is, significant correlation with Er.
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the subjects, and may also be due to changes induced in the
cells upon subcultures, insensitivity of certain biochemical
assays, and other random errors. One limitation of the cur-
rent study is that the sample microsphere cannot be used to
measure all biochemical and mechanical parameters. On the
other hand, for some biochemical tests, pooling of micro-
spheres is required to yield a single data point. As a result, it
is impossible to build a statistical model specifically multiple
regression, which describes how do the biochemical param-
eters contribute to the mechanical property of the micro-
spheres. Therefore, separate correlation coefficients between
the mechanical property and each of the biochemical pa-
rameter were calculated to reveal the associations between
each biochemical parameter and the mechanical property.
Nevertheless, the relative importance of different biochemi-
cal parameters in contributing to the mechanical property of
the microspheres cannot be determined.
Elastic modulus of the differentiating collagen–hMSC
microspheres is approaching although not achieving
that of the native cartilage
The microplate compression technique was also applied to
measure the Young’s modulus (E) of rabbit articular carti-
lage. The mean value was 511 411 kPa, which is compara-
ble to values reported elsewhere.64–67 The equation for Er of
the microspheres is Er¼ E
1 v2 ¼
k
a
 
D _d
D _d
¢  1
!
, which is re-
lated to Young’s modulus E via E¼Er · (1 v2). For positive-
Poisson-ratio materials, Poisson’s ratio, n, is between 0 and
0.5, and so E should be smaller than Er. The mean Er of the
differentiated collagen–hMSC microspheres on day 21 was
96 kPa and the corresponding E would have a value smaller
than that, say, 87 kPa if n is assumed to be 0.3. Thus, the
mean E of the differentiated microspheres was only around
20% of that of native cartilage. As a result, further stimuli for
chondrogenesis and new matrix production via prolonged
culture in the chondrogenic medium or mechanical stimu-
lation68–70 may be needed to further stiffen the engineered
microspheres before implantation.
Conclusion
The compositional mechanical relationship of collagen–
hMSC microspheres during chondrogenic differentiation has
been characterized. Particularly, the temporal change of the
reduced elastic modulus of the microspheres was positively
associated with newly deposited ECM components, includ-
ing GAGs and type II collagen, and with increasing matrix
organization in terms of collagen crosslinker density during
differentiation. The temporal changes in type I collagen and
total collagen were negatively associated with the reduced
elastic modulus, suggesting the matrix remodeling activity of
the differentiating hMSCs. This work illustrates the applica-
tion of the microplate compression method as a simple sen-
sitive and nondestructive monitoring tool for stem cell
differentiation in engineered constructs. This study contrib-
utes to future development of stem cell-based cartilage repair.
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